文献速递神经免疫

25-羟维生素D缺乏与芬兰孕产妇队列女性多发性硬化风险

25-Hydroxyvitamin D deficiency and risk of MS among women in the Finnish Maternity Cohort.
PubMed 文献 · Neurology · 2017-09-13

在芬兰孕产妇队列中开展前瞻性巢式病例对照研究,纳入1983至2009年确诊多发性硬化的1092例女性并按出生日期与居住地区匹配对照。结果显示25-羟维生素D每升高50 nmol/L,多发性硬化风险降低39%;水平低于30 nmol/L者风险升高。

要点

  • 25-羟维生素D每升高50 nmol/L,多发性硬化风险降低39%。
  • 25-羟维生素D低于30 nmol/L者多发性硬化风险升高43%。
  • 有至少2份样本者中,25-羟维生素D低于30 nmol/L者风险约高2倍。

核心结论

  • 结果直接支持维生素D缺乏是多发性硬化的危险因素,并强化了改善维生素D水平的公共卫生干预依据。

研究设计与样本

  • 通过医院与处方登记链接识别1983至2009年确诊多发性硬化的1092例女性,其中511例有至少2份血清样本。
  • 病例按出生日期(±2岁)与居住地区匹配最多3名对照,共2123名对照。
  • 25-羟维生素D采用化学发光法测定,用条件logistic回归校正采血年份、孕次与产次估计相对危险度。

主要发现

  • 25-羟维生素D升高50 nmol/L与多发性硬化风险降低39%相关(RR 0.61,95% CI 0.44-0.85,p=0.003)。
  • 25-羟维生素D低于30 nmol/L的女性较≥50 nmol/L者多发性硬化风险高43%(RR 1.43,95% CI 1.02-1.99,p=0.04)。
  • 有至少2份样本的女性中,25-羟维生素D低于30 nmol/L者较≥50 nmol/L者多发性硬化风险约高2倍(RR 2.02,95% CI 1.18-3.45,p=0.01)。

临床怎么用

  • 对育龄女性可关注25-羟维生素D水平,缺乏者按原文所述风险升高进行评估与随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether and to what extent vitamin D deficiency is associated with multiple sclerosis (MS) risk. METHODS: We conducted a prospective nested case-control study among women in the Finnish Maternity Cohort (FMC). The FMC had 1.8 million stored serum samples taken during the pregnancies of over 800,000 women at the time of this study. Through linkages with hospital and prescription registries, we identified 1,092 women with MS diagnosed between 1983 and 2009 with at least 1 serum sample collected prior to date of MS diagnosis; ≥2 serum samples were available for 511 cases. Cases were matched to up to 3 controls (n = 2,123) on date of birth (±2 years) and area of residence. 25-Hydroxyvitamin D (25[OH]D) levels were measured using a chemiluminescence assay. We used conditional logistic regression adjusted for year of sample collection, gravidity, and parity to estimate relative risks (RRs) and 95% confidence intervals (CIs). RESULTS: A 50 nmol/L increase in 25(OH)D was associated with a 39% reduced risk of MS (RR 0.61, 95% CI 0.44-0.85), p = 0.003. Women with 25(OH)D levels <30 nmol/L had a 43% higher MS risk (RR 1.43, 95% CI 1.02-1.99, p = 0.04) as compared to women with levels ≥50 nmol/L. In women with ≥2 samples, MS risk was 2-fold higher in women with 25(OH)D <30 nmol/L as compared to women with 25(OH)D ≥50 nmol/L (RR 2.02, 95% CI 1.18-3.45, p = 0.01). CONCLUSIONS: These results directly support vitamin D deficiency as a risk factor for MS and strengthen the rationale for broad public health interventions to improve vitamin D levels.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Munger KL, Hongell K, Åivo J, et al. 25-Hydroxyvitamin D deficiency and risk of MS among women in the Finnish Maternity Cohort. Neurology. 2017. PMID: 28904091. doi:10.1212/WNL.0000000000004489

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。